Literature DB >> 3988864

High-performance liquid chromatographic analysis of baclofen in plasma and urine of man after precolumn extraction and derivatization with o-phthaldialdehyde.

E W Wuis, R J Dirks, T B Vree, E van der Kleyn.   

Abstract

A reversed-phase high-performance liquid chromatographic method for the determination of the skeletal muscle relaxant baclofen in human plasma and urine is described. Cation-exchange extraction, precolumn derivatization with o-phthaldialdehyde, and on-column concentration precede fluorimetric detection (excitation at 340 nm, emission at 460 nm). The precision of the assay was always better than 6%. Recoveries of standards added to plasma and urine were 92% and 93%, respectively. With a sample size of 0.5 ml, a detection limit of a few nanograms, and the possibility of analysing up to four samples per hour, this method is suitable for pharmacokinetic studies. An example is presented.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3988864     DOI: 10.1016/0378-4347(85)80047-5

Source DB:  PubMed          Journal:  J Chromatogr


  6 in total

1.  CSF baclofen levels after intrathecal administration in severe spasticity.

Authors:  B Sallerin-Caute; Y Lazorthes; B Monsarrat; J Cros; R Bastide
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Spasticity and drug therapy.

Authors:  E W Wuis
Journal:  Pharm Weekbl Sci       Date:  1987-10-16

3.  Pharmacokinetics of baclofen in spastic patients receiving multiple oral doses.

Authors:  E W Wuis; M J Dirks; T B Vree; E Van der Kleijn
Journal:  Pharm Weekbl Sci       Date:  1990-04-27

4.  Validated Method for the Quantification of Baclofen in Human Plasma Using Solid-Phase Extraction and Liquid Chromatography-Tandem Mass Spectrometry.

Authors:  Limon Khatun Nahar; Rosa Elena Cordero; David Nutt; Anne Lingford-Hughes; Samuel Turton; Claire Durant; Sue Wilson; Sue Paterson
Journal:  J Anal Toxicol       Date:  2015-11-04       Impact factor: 3.367

5.  Plasma and urinary excretion kinetics of oral baclofen in healthy subjects.

Authors:  E W Wuis; M J Dirks; E F Termond; T B Vree; E Van der Kleijn
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  Metabolic and Pharmacokinetic Differentiation of STX209 and Racemic Baclofen in Humans.

Authors:  Raymundo Sanchez-Ponce; Li-Quan Wang; Wei Lu; Jana von Hehn; Maryann Cherubini; Roger Rush
Journal:  Metabolites       Date:  2012-09-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.